ReP USP - Resultado da busca

Artigo de periodico
Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein (2023)
Bitencourt, Natália Vitória ; Righetto, Gabriela Marinho; Camargo, Ilana Lopes Baratella da Cunha ; Godoy, Mariana Ortiz de ; Guido, Rafael Victorio Carvalho ; Oliva, Glaucius ; Santos Filho, Norival Alves ; Cilli, Eduardo Maffud
Fonte: Pharmaceutics. Unidade: IFSC
Assuntos: COVID-19, CORONAVIRUS, PEPTÍDEOS, RESISTÊNCIA MICROBIANA ÀS DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITENCOURT, Natália Vitória et al. Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein. Pharmaceutics, v. 15, n. 2, p. 436-1-436-17 + supplementary materials: 1-8, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15020436. Acesso em: 26 jun. 2024.
APA
Bitencourt, N. V., Righetto, G. M., Camargo, I. L. B. da C., Godoy, M. O. de, Guido, R. V. C., Oliva, G., et al. (2023). Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein. Pharmaceutics, 15( 2), 436-1-436-17 + supplementary materials: 1-8. doi:10.3390/pharmaceutics15020436
NLM
Bitencourt NV, Righetto GM, Camargo ILB da C, Godoy MO de, Guido RVC, Oliva G, Santos Filho NA, Cilli EM. Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein [Internet]. Pharmaceutics. 2023 ; 15( 2): 436-1-436-17 + supplementary materials: 1-8.[citado 2024 jun. 26 ] Available from: https://doi.org/10.3390/pharmaceutics15020436
Vancouver
Bitencourt NV, Righetto GM, Camargo ILB da C, Godoy MO de, Guido RVC, Oliva G, Santos Filho NA, Cilli EM. Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein [Internet]. Pharmaceutics. 2023 ; 15( 2): 436-1-436-17 + supplementary materials: 1-8.[citado 2024 jun. 26 ] Available from: https://doi.org/10.3390/pharmaceutics15020436
Artigo de periodico
Amino acid polymorphisms on the Brazilian strain of yellow fever virus methyltransferase are related to the host’s immune evasion mediated by type I interferon (2023)
Furtado, Nathália Dias ; Mello, Iasmim Silva de; Godoy, Andre Schutzer de ; Noske, Gabriela Dias; Oliva, Glaucius ; Canard, Bruno; Decroly, Etienne ; Bonaldo, Myrna Cristina
Fonte: Viruses. Unidade: IFSC
Assuntos: FEBRE AMARELA, FLAVIVIRUS, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FURTADO, Nathália Dias et al. Amino acid polymorphisms on the Brazilian strain of yellow fever virus methyltransferase are related to the host’s immune evasion mediated by type I interferon. Viruses, v. 15, n. Ja 2023, p. 191-1-191-18 + supplementary materials, 2023Tradução . . Disponível em: https://doi.org/10.3390/v15010191. Acesso em: 26 jun. 2024.
APA
Furtado, N. D., Mello, I. S. de, Godoy, A. S. de, Noske, G. D., Oliva, G., Canard, B., et al. (2023). Amino acid polymorphisms on the Brazilian strain of yellow fever virus methyltransferase are related to the host’s immune evasion mediated by type I interferon. Viruses, 15( Ja 2023), 191-1-191-18 + supplementary materials. doi:10.3390/v15010191
NLM
Furtado ND, Mello IS de, Godoy AS de, Noske GD, Oliva G, Canard B, Decroly E, Bonaldo MC. Amino acid polymorphisms on the Brazilian strain of yellow fever virus methyltransferase are related to the host’s immune evasion mediated by type I interferon [Internet]. Viruses. 2023 ; 15( Ja 2023): 191-1-191-18 + supplementary materials.[citado 2024 jun. 26 ] Available from: https://doi.org/10.3390/v15010191
Vancouver
Furtado ND, Mello IS de, Godoy AS de, Noske GD, Oliva G, Canard B, Decroly E, Bonaldo MC. Amino acid polymorphisms on the Brazilian strain of yellow fever virus methyltransferase are related to the host’s immune evasion mediated by type I interferon [Internet]. Viruses. 2023 ; 15( Ja 2023): 191-1-191-18 + supplementary materials.[citado 2024 jun. 26 ] Available from: https://doi.org/10.3390/v15010191
Artigo de periodico
Natural compounds as non-nucleoside inhibitors of zika virus polymerase through integration of in silico and in vitro approaches (2022)
Ramos, Paulo Ricardo Pimenta da Silva ; Mottin, Melina ; Lima, Caroline Sprengel ; Assis, Letícia R.; Oliveira, Ketllyn Zagato de; Mesquita, Nathalya Cristina de Moraes Roso; Cassani, Natasha Marques ; Santos, Igor Andrade ; Borba, Joyce Villa Verde Bastos ; Costa, Vinícius Alexandre Fiaia; Junior Neves, Bruno ; Guido, Rafael Victorio Carvalho ; Oliva, Glaucius ; Jardim, Ana Carolina Gomes ; Regasini, Luis Octávio; Andrade, Carolina Horta
Fonte: Pharmaceuticals. Unidade: IFSC
Assuntos: ZIKA VÍRUS, PLANEJAMENTO DE FÁRMACOS, QUÍMICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMOS, Paulo Ricardo Pimenta da Silva et al. Natural compounds as non-nucleoside inhibitors of zika virus polymerase through integration of in silico and in vitro approaches. Pharmaceuticals, v. 15, n. 12, p. 1493-1-1493-17, 2022Tradução . . Disponível em: https://doi.org/10.3390/ph15121493. Acesso em: 26 jun. 2024.
APA
Ramos, P. R. P. da S., Mottin, M., Lima, C. S., Assis, L. R., Oliveira, K. Z. de, Mesquita, N. C. de M. R., et al. (2022). Natural compounds as non-nucleoside inhibitors of zika virus polymerase through integration of in silico and in vitro approaches. Pharmaceuticals, 15( 12), 1493-1-1493-17. doi:10.3390/ph15121493
NLM
Ramos PRP da S, Mottin M, Lima CS, Assis LR, Oliveira KZ de, Mesquita NC de MR, Cassani NM, Santos IA, Borba JVVB, Costa VAF, Junior Neves B, Guido RVC, Oliva G, Jardim ACG, Regasini LO, Andrade CH. Natural compounds as non-nucleoside inhibitors of zika virus polymerase through integration of in silico and in vitro approaches [Internet]. Pharmaceuticals. 2022 ; 15( 12): 1493-1-1493-17.[citado 2024 jun. 26 ] Available from: https://doi.org/10.3390/ph15121493
Vancouver
Ramos PRP da S, Mottin M, Lima CS, Assis LR, Oliveira KZ de, Mesquita NC de MR, Cassani NM, Santos IA, Borba JVVB, Costa VAF, Junior Neves B, Guido RVC, Oliva G, Jardim ACG, Regasini LO, Andrade CH. Natural compounds as non-nucleoside inhibitors of zika virus polymerase through integration of in silico and in vitro approaches [Internet]. Pharmaceuticals. 2022 ; 15( 12): 1493-1-1493-17.[citado 2024 jun. 26 ] Available from: https://doi.org/10.3390/ph15121493
Artigo de periodico
The Antifungal itraconazole is a potent inhibitor of Chikungunya virus replication (2022)
Policastro, Lucca Rocha ; Dolci, Isabela; Godoy, Andre Schutzer de ; Silva Júnior, José V. J.; Ruiz, Uriel Enrique Aquino; Santos, Igor A. ; Jardim, Ana C. G. ; Samby, Kirandeep; Burrows, Jeremy N.; Wells, Timothy N. C.; Gil, Laura Helena Vega Gonzales; Oliva, Glaucius ; Fernandes, Rafaela Sachetto
Fonte: Viruses. Unidade: IFSC
Assuntos: FEBRE AMARELA, FLAVIVIRUS, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
POLICASTRO, Lucca Rocha et al. The Antifungal itraconazole is a potent inhibitor of Chikungunya virus replication. Viruses, v. 14, n. 7, p. 1351-1-1351-12, 2022Tradução . . Disponível em: https://doi.org/10.3390/v14071351. Acesso em: 26 jun. 2024.
APA
Policastro, L. R., Dolci, I., Godoy, A. S. de, Silva Júnior, J. V. J., Ruiz, U. E. A., Santos, I. A., et al. (2022). The Antifungal itraconazole is a potent inhibitor of Chikungunya virus replication. Viruses, 14( 7), 1351-1-1351-12. doi:10.3390/v14071351
NLM
Policastro LR, Dolci I, Godoy AS de, Silva Júnior JVJ, Ruiz UEA, Santos IA, Jardim ACG, Samby K, Burrows JN, Wells TNC, Gil LHVG, Oliva G, Fernandes RS. The Antifungal itraconazole is a potent inhibitor of Chikungunya virus replication [Internet]. Viruses. 2022 ; 14( 7): 1351-1-1351-12.[citado 2024 jun. 26 ] Available from: https://doi.org/10.3390/v14071351
Vancouver
Policastro LR, Dolci I, Godoy AS de, Silva Júnior JVJ, Ruiz UEA, Santos IA, Jardim ACG, Samby K, Burrows JN, Wells TNC, Gil LHVG, Oliva G, Fernandes RS. The Antifungal itraconazole is a potent inhibitor of Chikungunya virus replication [Internet]. Viruses. 2022 ; 14( 7): 1351-1-1351-12.[citado 2024 jun. 26 ] Available from: https://doi.org/10.3390/v14071351
Artigo de periodico
Non-Toxic dimeric peptides derived from the bothropstoxin-I are potent SARS-CoV-2 and papain-like protease inhibitors (2021)
Freire, Marjorie Caroline Liberato Cavalcanti ; Noske, Gabriela Dias; Bitencourt, Natália V.; Sanches, Paulo R. S.; Santos-Filho, Norival A.; Oliveira, Victor Gawriljuk Ferraro; Souza, Eduardo Pereira de ; Nogueira, Victor Henrique Rabesquine ; Godoy, Mariana Ortiz de; Nakamura, Aline Minali; Fernandes, Rafaela Sachetto ; Godoy, Andre Schutzer de ; Juliano, Maria A.; Peres, Bianca de Miranda ; Barbosa, Cecília G.; Moraes, Carolina B.; Freitas Junior, Lucio Holanda Gondim de ; Cilli, Eduardo Maffud ; Guido, Rafael Victorio Carvalho ; Oliva, Glaucius
Fonte: Molecules. Unidades: IFSC, ICB
Assuntos: COVID-19, CORONAVIRUS, PLANEJAMENTO DE FÁRMACOS, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREIRE, Marjorie Caroline Liberato Cavalcanti et al. Non-Toxic dimeric peptides derived from the bothropstoxin-I are potent SARS-CoV-2 and papain-like protease inhibitors. Molecules, v. 26, n. 16, p. 4896-1-4896-17, 2021Tradução . . Disponível em: https://doi.org/10.3390/molecules26164896. Acesso em: 26 jun. 2024.
APA
Freire, M. C. L. C., Noske, G. D., Bitencourt, N. V., Sanches, P. R. S., Santos-Filho, N. A., Oliveira, V. G. F., et al. (2021). Non-Toxic dimeric peptides derived from the bothropstoxin-I are potent SARS-CoV-2 and papain-like protease inhibitors. Molecules, 26( 16), 4896-1-4896-17. doi:10.3390/molecules26164896
NLM
Freire MCLC, Noske GD, Bitencourt NV, Sanches PRS, Santos-Filho NA, Oliveira VGF, Souza EP de, Nogueira VHR, Godoy MO de, Nakamura AM, Fernandes RS, Godoy AS de, Juliano MA, Peres B de M, Barbosa CG, Moraes CB, Freitas Junior LHG de, Cilli EM, Guido RVC, Oliva G. Non-Toxic dimeric peptides derived from the bothropstoxin-I are potent SARS-CoV-2 and papain-like protease inhibitors [Internet]. Molecules. 2021 ; 26( 16): 4896-1-4896-17.[citado 2024 jun. 26 ] Available from: https://doi.org/10.3390/molecules26164896
Vancouver
Freire MCLC, Noske GD, Bitencourt NV, Sanches PRS, Santos-Filho NA, Oliveira VGF, Souza EP de, Nogueira VHR, Godoy MO de, Nakamura AM, Fernandes RS, Godoy AS de, Juliano MA, Peres B de M, Barbosa CG, Moraes CB, Freitas Junior LHG de, Cilli EM, Guido RVC, Oliva G. Non-Toxic dimeric peptides derived from the bothropstoxin-I are potent SARS-CoV-2 and papain-like protease inhibitors [Internet]. Molecules. 2021 ; 26( 16): 4896-1-4896-17.[citado 2024 jun. 26 ] Available from: https://doi.org/10.3390/molecules26164896

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos

Grupo de pesquisa

Agência de fomento

Afiliação dos autores externos normalizada